[Current treatment of Parkinson syndrome with L-dopa].
D000284:Administration, Oral; D001812:Blood-Brain Barrier; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004296:Dopa Decarboxylase / Q000627:therapeutic use; D004357:Drug Synergism; D004569:Electroencephalography; D005116:Extrapyramidal Tracts / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000517:prevention & control; D010300:Parkinson Disease / Q000188:drug therapy*; D011581:Psychological Tests
D004295:Dihydroxyphenylalanine; D004296:Dopa Decarboxylase
W sprawie nowoczesnego leczenia zespołu parkinsonowskiego preparatem L-dopa.